Recent Price Movement and Market Context
The stock has been under pressure for several sessions, recording a consecutive three-day fall that has resulted in an 8.56% loss over this period. On the day in question, the share price hit a new 52-week low of ₹1,909.9, marking a 4.49% intraday decline. This underperformance is slightly worse than the Pharmaceuticals & Drugs sector, which itself fell by 3.62%, indicating sector-wide weakness but with Mankind Pharma lagging marginally behind.
Trading volumes have increased, with delivery volumes on 20 Mar rising by 83.22% compared to the five-day average, suggesting heightened investor activity. However, the weighted average price indicates that more shares were traded closer to the day’s low, signalling selling pressure. ...
Read full news article












